Literature DB >> 20934924

A liquid chromatography-tandem mass spectrometric method for quantification of curcuminoids in cell medium and mouse plasma.

U V R Vijaya Saradhi1, Yonghua Ling, Jiang Wang, Ming Chiu, Eric B Schwartz, James R Fuchs, Kenneth K Chan, Zhongfa Liu.   

Abstract

Curcumin and tetrahydrocurcumin (THC) have been found as potent DNMT1 inhibitors, but they suffer from low oral bioavailability and rapid metabolism in vivo. To circumvent these problems, two curcumin analogs: 1,7-bis(3,4-dimethoxyphenyl)-4,4-dimethyl-1,6-heptadiene-3,5-dione (TMC) and 1,7-bis(3,4-dimethoxyphenyl)-4-cyclohexyl-1,6-heptadiene-3,5-dione (DMCHC) have been synthesized to enhance their stability by blocking the two metabolic sites, the phenolic and C4 methylene moieties. Both compounds have shown inhibitory activity on M. SssI similar to that of curcumin and THC (Poster, M1114, AAPS, 2009). Preclinical pharmacokinetics has yet to be performed. In this paper, a simple liquid chromatography-tandem mass spectrometric method was developed for the determination of these four curcuminoids in cell medium and mouse plasma. The method showed linearity from 1 to 1000 ng/mL with the lower limit of quantification of 1 ng/mL in cell medium, and 5 ng/mL in mouse plasma for all test curcuminoids. The within-day coefficients of variation were found to be below 15% and the accuracy was in the range of 85-115%. This method was subsequently used to evaluate their stability in these matrices and a pilot pharmacokinetics of curcumin, DMCHC and TMC in mice after an intraperitoneal (i.p.) cassette dosing of 10mg/kg each. Curcuminoids degraded in two phases with terminal half lives of 186, 813, 724, and 2000 min for curcumin, THC, TMC, and DMCHC, respectively, in cell culture medium. In plasma, their respective half lives were 111, 232, 1202 and 3000 min. These data demonstrated that their stability is in the order curcumin<THC<TMC<DMCHC in both matrices. Following an i.p. cassette dose, both TMC and DMCHC showed the prolonged elimination half life (1.0, 1.0 h, respectively vs 0.4h for curcumin) and an increased drug exposure as described by the area under the curve (0.64, 0.98 μM h, respectively vs 0.4 μM h for curcumin). Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20934924      PMCID: PMC2975763          DOI: 10.1016/j.jchromb.2010.08.039

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  24 in total

1.  Design and development of water-soluble curcumin conjugates as potential anticancer agents.

Authors:  Ahmad Safavy; Kevin P Raisch; Sushma Mantena; Leisa L Sanford; Simon W Sham; N Rama Krishna; James A Bonner
Journal:  J Med Chem       Date:  2007-11-01       Impact factor: 7.446

2.  Curcumin in plasma and urine: quantitation by high-performance liquid chromatography.

Authors:  Dennis D Heath; Milagros A Pruitt; Dean E Brenner; Cheryl L Rock
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-01-05       Impact factor: 3.205

3.  Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.

Authors:  Anchang Liu; Hongxiang Lou; Lixia Zhao; Peihong Fan
Journal:  J Pharm Biomed Anal       Date:  2005-11-28       Impact factor: 3.935

Review 4.  Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.

Authors:  Miguel López-Lázaro
Journal:  Mol Nutr Food Res       Date:  2008-06       Impact factor: 5.914

Review 5.  Highly active anticancer curcumin analogues.

Authors:  Cara A Mosley; Dennis C Liotta; James P Snyder
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 6.  Modulation of transcription factors by curcumin.

Authors:  Shishir Shishodia; Tulika Singh; Madan M Chaturvedi
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

Review 7.  Clinical studies with curcumin.

Authors:  Chih-Hung Hsu; Ann-Lii Cheng
Journal:  Adv Exp Med Biol       Date:  2007       Impact factor: 2.622

8.  Human glutathione S-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells.

Authors:  Mustafa Usta; Heleen M Wortelboer; Jacques Vervoort; Marelle G Boersma; Ivonne M C M Rietjens; Peter J van Bladeren; Nicole H P Cnubben
Journal:  Chem Res Toxicol       Date:  2007-11-01       Impact factor: 3.739

9.  Curcumin is a potent DNA hypomethylation agent.

Authors:  Zhongfa Liu; Zhiliang Xie; William Jones; Ryan E Pavlovicz; Shujun Liu; Jianhua Yu; Pui-kai Li; Jiayuh Lin; Jame R Fuchs; Guido Marcucci; Chenglong Li; Kenneth K Chan
Journal:  Bioorg Med Chem Lett       Date:  2008-12-14       Impact factor: 2.823

10.  Curcumin derivatives: molecular basis of their anti-cancer activity.

Authors:  Valentina Basile; Erika Ferrari; Sandra Lazzari; Silvia Belluti; Francesca Pignedoli; Carol Imbriano
Journal:  Biochem Pharmacol       Date:  2009-07-04       Impact factor: 5.858

View more
  14 in total

1.  Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice.

Authors:  Liu Zhongfa; Ming Chiu; Jiang Wang; Wei Chen; Winston Yen; Patty Fan-Havard; Lisa D Yee; Kenneth K Chan
Journal:  Cancer Chemother Pharmacol       Date:  2011-10-04       Impact factor: 3.333

Review 2.  A critical review of analytical methods for determination of curcuminoids in turmeric.

Authors:  Venkata Subba Rao Kotra; Laishram Satyabanta; Tridib Kumar Goswami
Journal:  J Food Sci Technol       Date:  2019-08-05       Impact factor: 2.701

3.  A liquid chromatography-tandem mass spectrometric method for quantification of curcumin-O-glucuronide and curcumin in human plasma.

Authors:  Wei Chen; Patty Fan-Havard; Lisa D Yee; Yu Cao; Gary D Stoner; Kenneth K Chan; Zhongfa Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-05-26       Impact factor: 3.205

4.  A high-throughput quantification method of curcuminoids and curcumin metabolites in human plasma via high-performance liquid chromatography/tandem mass spectrometry.

Authors:  Yu Cao; Ronald X Xu; Zhongfa Liu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-15       Impact factor: 3.205

5.  Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometry.

Authors:  Shu Fang Soh; Chiung-Kuei Huang; Soo Ok Lee; Defeng Xu; Shuyuan Yeh; Jun Li; Eu Leong Yong; Yinhan Gong; Chawnshang Chang
Journal:  J Pharm Biomed Anal       Date:  2013-08-27       Impact factor: 3.935

6.  Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.

Authors:  Matthew A Bill; Courtney Nicholas; Thomas A Mace; Jonathan P Etter; Chenglong Li; Eric B Schwartz; James R Fuchs; Gregory S Young; Li Lin; Jiayuh Lin; Lei He; Mitch Phelps; Pui-Kai Li; Gregory B Lesinski
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

7.  Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats.

Authors:  Wei Ling Lau; Mahyar Khazaeli; Javad Savoj; Kasim Manekia; Maria Bangash; Roshni G Thakurta; Anhthu Dang; Nosratola D Vaziri; Bhupinder Singh
Journal:  Pharmacol Res Perspect       Date:  2018-02-19

8.  Pterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent Mechanism.

Authors:  María Benlloch; Elena Obrador; Soraya L Valles; María L Rodriguez; J Antoni Sirerol; Javier Alcácer; José A Pellicer; Rosario Salvador; Concha Cerdá; Guillermo T Sáez; José M Estrela
Journal:  Antioxid Redox Signal       Date:  2016-03-15       Impact factor: 8.401

Review 9.  The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin.

Authors:  Ching-Shu Lai; Chi-Tang Ho; Min-Hsiung Pan
Journal:  Biomolecules       Date:  2020-05-29

Review 10.  Obstacles against the Marketing of Curcumin as a Drug.

Authors:  Kambiz Hassanzadeh; Lucia Buccarello; Jessica Dragotto; Asadollah Mohammadi; Massimo Corbo; Marco Feligioni
Journal:  Int J Mol Sci       Date:  2020-09-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.